Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the seven brokerages that are currently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation, four have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $46.60.
A number of research analysts have recently weighed in on the company. Stifel Nicolaus cut their price target on Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a research note on Thursday, February 20th. Piper Sandler cut their price target on Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a research note on Thursday, February 20th.
Read Our Latest Stock Analysis on Trupanion
Trupanion Stock Up 2.4 %
Trupanion (NASDAQ:TRUP – Get Free Report) last posted its quarterly earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). The company had revenue of $337.31 million during the quarter, compared to analyst estimates of $335.41 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. On average, analysts anticipate that Trupanion will post 0.13 EPS for the current year.
Insider Buying and Selling
In related news, CEO Margaret Tooth sold 2,294 shares of the firm’s stock in a transaction on Tuesday, March 4th. The stock was sold at an average price of $31.39, for a total transaction of $72,008.66. Following the sale, the chief executive officer now owns 118,784 shares of the company’s stock, valued at approximately $3,728,629.76. This trade represents a 1.89 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Fawwad Qureshi sold 1,373 shares of the firm’s stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $34.22, for a total value of $46,984.06. Following the sale, the chief financial officer now directly owns 2,416 shares in the company, valued at $82,675.52. The trade was a 36.24 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 3,859 shares of company stock valued at $128,593. 5.50% of the stock is owned by company insiders.
Hedge Funds Weigh In On Trupanion
A number of large investors have recently added to or reduced their stakes in TRUP. SBI Securities Co. Ltd. bought a new position in Trupanion during the 4th quarter worth about $25,000. Jones Financial Companies Lllp increased its holdings in Trupanion by 71.7% during the 4th quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 238 shares in the last quarter. Quest Partners LLC bought a new position in Trupanion during the 3rd quarter worth about $37,000. Quarry LP bought a new position in Trupanion during the 4th quarter worth about $39,000. Finally, Wilmington Savings Fund Society FSB bought a new position in Trupanion during the 3rd quarter worth about $54,000.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Read More
- Five stocks we like better than Trupanion
- Stock Sentiment Analysis: How it Works
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- What is a Death Cross in Stocks?
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.